TENARIS SA-ADR (TS)       32.52  -1.41 (-4.16%)

32.52  -1.41 (-4.16%)

US88031M1099 - ADR - After market: 32.52 0 (0%)


Fundamental Rating

7

Overall TS gets a fundamental rating of 7 out of 10. We evaluated TS against 91 industry peers in the Energy Equipment & Services industry. TS scores excellent points on both the profitability and health parts. This is a solid base for a good stock. TS is evaluated to be cheap and growing strongly. This does not happen too often! This could make TS a good candidate for value investing.




Profitability

Profitability Rating

7

TS's Return On Assets of 12.55% is amongst the best returns of the industry. TS outperforms 94% of its industry peers. The industry average Return On Assets is -1.04%.
TS's Return On Equity of 16.02% is amongst the best of the industry. TS does better than the industry average Return On Equity of 10.86%.

TS has a Profit Margin of 20.75%. This is amongst the best returns in the industry. The industry average is -0.19%. TS outperforms 94% of its industry peers.
The Piotroski-F score of TS is 6.00. This is a neutral score and indicates average health and profitability for TS.
VS Industry

ROA (12.55%) VS Industry: 94% outperformed.

-226.86
42,190.18

ROE (16.02%) VS Industry: 68% outperformed.

0.23
39.13

Profit Margin (20.75%) VS Industry: 94% outperformed.

-95.78
67,560.47

Valuation

Valuation Rating

7

The Price/Earnings Ratio is 9.08, which indicates a very decent valuation of TS.
Compared to an average industry Price/Earning Ratio of 21.40, TS is valued rather cheaply. On top of this TS is cheaper than 84% of the companies listed in the same industry.
With a Forward Price/Earnings Ratio of 9.70, the valuation of TS can be described as very reasonable.
TS's low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

When comparing the Enterprise Value to EBITDA ratio of TS to the average industry ratio of 9.29, TS is valued rather cheaply.
When comparing the current price to the book value of TS, we can conclude it is valued correctly. It is trading at 1.45 times its book value.
When comparing the price book ratio of TS to the average industry price book ratio of 1.37, TS is valued in line with its industry peers.
VS Industry

Price/Earnings (9.08) VS Industry: 84% outperformed.

471.90
0.05

Price/Book (1.45) VS Industry: 46% outperformed.

10.20
0.21

Enterprise Value/ EBITDA (6.49) VS Industry: 72% outperformed.

255.74
1.55

Growth

Growth Rating

7

TS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 152.11%, which is quite impressive.
TS shows a strong growth in Earnings Per Share. Measured over the last 5 years, the EPS has been growing by 104.50% yearly.
Looking at the last year, TS shows a very strong growth in Revenue. The Revenue has grown by 82.31%.
TS is expected to show quite a strong growth in Revenue. In the coming 5 years, the Revenue will grow by 13.87% yearly.

When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
TS is expected to show a small growth in Earnings Per Share. In the coming 5 years, the EPS will grow by 2.61% yearly.
TS shows a small growth in Revenue. Measured over the last 5 years, the Revenue has been growing by 8.72% yearly.
When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS104.5% 7.92% 152.11% 89.87% 34.28% 13.78% 2.61%
Revenue8.72% -5.22% 82.31% 75.99% 39.22% 22.53% 13.87%

Health

Health Rating

8

TS has a Current Ratio of 2.73. This indicates that TS is financially healthy and has no problem in meeting its short term obligations.
When comparing the Current Ratio to an average industry Current Ratio of 1.78, TS is better placed than the average industry peer to meet its short term obligations.
The Debt to Equity ratio of TS is way better than the industry averages. TS has a better rating than 88% of its industry peers.
TS has an Altman-Z score of 5.73. This indicates that TS is financially healthy and little risk of bankruptcy at the moment.

TS has one of the better Altman-Z scores in its industry. It is much better than the industry average of 1.62. TS has a better score than 94% of its industry peers.
TS has a Quick Ratio of 1.40. This is a normal value and indicates that TS is financially healthy and should not expect problems in meeting its short term obligations.
TS has a Quick Ratio comparable to the industry average, which is at 1.37.
The Piotroski-F score of TS is 6.00. This is a neutral score and indicates average health and profitability for TS.
VS Industry

Debt/Equity (0.01) VS Industry: 88% outperformed.

5.89
0.00

Quick Ratio (1.4) VS Industry: 52% outperformed.

0.12
8.05

Current Ratio (2.73) VS Industry: 80% outperformed.

0.12
8.35

Altman-Z (5.73) VS Industry: 94% outperformed.

-2,347.49
37.50

Dividend

Dividend Rating

5

22.88% of the earnings are spent on dividend by TS. This is a low number and sustainable payout ratio.
TS has paid a dividend for at least 10 years, which is a reliable track record.
TS has a Yearly Dividend Yield of 2.69%. Purely for dividend investing, there may be better candidates out there.

TS's Dividend Yield is comparable with the industry average which is at 1.98.
Compared to an average S&P500 Dividend Yield of 2.43, TS has a dividend comparable with the average S&P500 company.
VS Industry

Dividend Yield (2.69%) VS Industry: 60% outperformed.

0.19
11.44
TS Daily chart

TENARIS SA-ADR32.52

NYSE:TS (12/5/2022, 7:06:04 PM)-1.41 (-4.16%)

After market: 32.52 0 (0%)

Chartmill FA Rating
GICS Sector Energy
GICS IndustryGroup Energy
GICS Industry Energy Equipment & Services
Earnings (Last) 11-03 2022-11-03/amc Earnings (Next) 02-14 2023-02-14
Ins Owners N/A Inst Owners 12.41%
Market Cap 19.20B Analysts 81.18
Valuation
PE 9.08 Fwd PE 9.7
PEG (NY) 0.1 PEG (5Y) 0.09
P/S 1.88 P/B 1.45
EV/EBITDA 6.49
Dividend
Dividend Yield 2.69% Dividend Growth N/A
DP 22.88% Ex-Date 11-21 2022-11-21 (0.17)
Growth
EPS 1Y 152.11% EPS 3Y 7.92%
EPS 5Y 104.5% EPS growth Q2Q 82.14%
EPS Next Y 89.87% EPS Next 2Y 34.28%
EPS Next 3Y 13.78% EPS Next 5Y 2.61%
Revenue growth 1Y 82.31% Revenue growth 3Y -5.22%
Revenue growth 5Y 8.72% Revenue growth Q2Q 69.63%
Revenue Next Year 75.99% Revenue Next 2Y 39.22%
Revenue Next 3Y 22.53% Revenue Next 5Y 13.87%
Health
Current Ratio 2.73 Quick Ratio 1.4
Altman-Z 5.73 F-Score 6
Debt/Equity 0.01 WACC 10.65%
ROIC/WACC 1.61
Profitability
ROA 12.55% ROE 16.02%
ROICexgc 17.1% ROIC 13.73%
PM 20.75% OM 22.36%
Asset Turnover 0.6

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA